On August 22^nd, 2019, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the field of Medical Science (Approval Notice).

General Field: Medical Science

Position at the Time of Case Filing: Senior Scientist

Country of Origin: India

State of Residence at the Time of Filing: Arizona

Approval Notice Date: August 22^nd, 2019

Processing Time: 8 months, 5 days

Case Summary:

Described by a prominent professor as an “esteemed and respected individual in the field”, our client, a senior scientist from India, has worked tirelessly in medical science for many years. His diligent efforts have resulted in significant contributions to the field, particularly focusing on conducting research to benefit the development of more effective therapies for virus induced cancers. One recent area in which he has specialized includes his use of next-generation sequencing (NGS) methodologies to track cancer mutations, aid in biomarker discovery, and track rare variants of different viruses. Our client’s work has various societal benefits and in fact, the applications of these methodologies are effectively endless in a variety of areas such as personalized medicine and tailored drug therapies.

When he first contacted North America Immigration Law Group (WeGreened.com) to assist him with I-140 petition, our team immediately set out to assess his academic and professional credentials. At the time we filed his case, the 11 peerreviewed scientific articles he has published have been cited 411 times by independent and leading researchers from prestigious institutions and organizations around the world, which indicates the major significance of his work. In addition, our client has also impacted the scientific community by conducting 44 peer reviews. His service to these publications has been invaluable, as it demonstrates that his expertise and judgment are widely respected throughout the field. All the information we gathered was used to persuade the USCIS that our client’s work is extremely important to the United States, and we tailor-made the EB-1A petition to demonstrate that our client’s research is particularly original.

Additionally, we customized our client’s petition letter with charts and graphs to highlight his major contributions. The visualization of data clearly distinguishes him from other researchers in the endeavor, as many of his works have been among the most-cited in the field over the years. We also included 6 recommendation letters contributed by other influential experts, one of whom noted: “With [Client]’s ongoing focus on afflictions like cancer and Hepatitis B, his discovery of additional knowledge that aids medical researchers and practitioners is all but guaranteed – since past and present results are a strong indicator of future success.”

Although we presented a strong case to the USCIS, our client’s EB-1A petition was issued a Request for Evidence (RFE). Our team strategized and put together a solid response to the RFE, which ultimately led to case approval. We are pleased that we managed to convince the USCIS that our client is an extraordinary researcher whose work is widely applied in the area of medical science. We congratulate him on the approved EB-1A petition, and thank him for choosing us to represent his case.